News
FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder – Primary Ovarian Insufficiency
LIBERTY, Mo., Oct. 18, 2022 /PRNewswire/ -- Vitti Labs, an AATB Accredited Tissue Bank focused on life science research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has approved their Investigational New Drug...
Sign up for Updates, Promotions, and More…
Vitti Labs Announces FDA Approval of Phase II IND Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Pulmonary Fibrosis Secondary to Novel Corona Virus Infection (COVID-19)
LIBERTY, Mo., May 2, 2022 /PRNewswire/ -- Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced today that the U.S. Food and Drug...
The future of healthcare: Harnessing the potential of regenerative medicine
Once considered the work of science fiction, regenerative medicine is now showing real potential in treating a range of health conditions by effectively enabling the body to heal itself, offering...
3D-print biomedical devices in study may open up new possibilities
Team of scientists say they have developed a highly conductive 3D printing ink that can build circuits in hydrogel to create devices that can be used to monitor heart rate and stimulate nerves....
Scientists’ use of hydrogel materials leads to stem cells developing like human embryos
Materials scientists at UNSW Sydney have shown that human pluripotent stem cells in a lab can initiate a process resembling the gastrulation phase—where cells begin differentiating into new cell...
Why Regenerative Medicine Is Vital In The Future Of Healthcare?
In the not-too-distant future, regenerative medicine may well become the go-to approach for treating many of our most serious illnesses. This type of medicine focuses on repairing and regenerating...